Skip to main content

Table 1 Laboratory tests during hospitalization

From: A case report of an atypical haemolytic uremic syndrome in pregnancy: something wicked this way comes

Day

Hb g/dL

PLTs

*109/L

WBC *109/L

INR

aPTT sec

Fibr mg/dL

Creat mg/dL

BUN mg/dL

AST/ALT

UI/L

LDH UI/L

Alb g/L

ATIII %

K+ mmol/L

Glu mg/dL

Others

1, pre- manual removal of placenta

7.1

174

12.7

1.02

30

257

     

66

   

1, post-MRP

9

69

11.5

1.18

46.7

250

1

14

   

41

 

124

 

1, PACU

6.7

40

17.2

1.14

43.8

260

1.4

18

76 / <5

1789

 

64

5.2

104

DD 28,628 ng/mL; TBil 1.8 mg/dL

1,ICU admission

8.2

39

17.1

1.12

45.5

271

1.6

20

n.d./ 27

2187

22

60

5.5

86

DD 21,098 ng/mL, TBil 1.5 mg/dL, Mg++ 1.3 mmol/L, direct Coombs test neg

2, ICU

6.9

29

14.5

1

47.2

360

2.1

21

105/40

2030

24

52

5.6

85

DD 7923 ng/mL, Sch neg, Apt < 7.75, ADAMTS13 Ag 424.8 ng/mL, ADAMTS13 Act 43.3%; B2 neg, aCL neg, LAC neg, TnI 1409

2, ICU

7.7

31

13.7

0.9

42.3

395

2.3

25

99/45

2356

22

60

5.9

104

DD 4930 ng/mL, Apt < 7.7, TnI 943

3, ICU

6.8

33

15.3

   

3

34

56/27

1743

23

 

5.4

102

Sch POS, TnI 493

3, ICU

5.8

25

10.6

            

3, ICU

7.1

23

11.4

0.95

37.8

410

3.4

38

n.d./15

1484

25

80

4.4

104

 

4, ICU

6.9

27

8.5

0.93

35.5

393

3.9

46

33/11

1492

22

82

4.2

76

DD 3726 ng/mL, Sch neg, Apt < 7.7 mg/dL, Prot 0.34 g/L, C3c 82.5 mg/dL, C4 12.1 mg/dL, CH50 14.7 Ueq/mL

4, ICU

8.6

26

10

0.93

35.1

405

4

51

36/9

1690

22

97

 

90

DD 4823 ng/mL

5, ICU

7.9

24

9.5

0.99

36.1

360

4.3

58

26/ <5

1381

28

100

 

135

Sch neg, Apt < 7.7, C3c 95.2 mg/dL, C4 15.5 mg/dL, CH50 17.8 Ueq/mL

6

6.4

24

9.5

   

4.7

74

n.d./ <5

1669

28

 

4.1

114

 

7

7.7

20

10.4

   

4.6

96

n.d./ <5

1730

26

  

99

 

8

7.5

29

10.5

   

4.4

92

n.d./ <5

1312

26

 

4.2

  

9

7.4

38

7.8

   

3.8

95

n.d./ <5

1281

26

 

3.2

118

Apt < 7.75 mg/dL

10

6.8

41

9.4

            

11

9.1

56

10

   

2.5

70

n.d./ <5

1131

31

 

3.3

83

C3c 138 mg/dL, C4 22.9 mg/dL

12

8.9

67

9.8

   

1.9

47

n.d./ <5

 

29

 

3.1

78

Apt < 7.75 mg/dL

13

8.7

98

8.9

   

1.4

35

n.d./ <5

872

30

 

3

68

 

14

9.2

132

8.6

   

1.4

27

n.d./ <5

726

30

 

3.5

67

 

15

8.8

160

8

   

1.2

19

n.d./ <5

631

28

 

3.1

74

 

42

12.5

213

8.4

   

0.79

30

 

195

  

3.3

 

Apt 121 mg/dL, C3c 127 mg/dL, C4 31.8 mg/dL

  1. DD D-dimer level, TBil Total bilirubin, Sch Schistocytes, Apt Aptoglobin (n.v. 45–320 mg/dL), ADAMTS13 Ag ADAMTS 13 antigen (normal values 520–960 ng/mL), ADAMTS13 Act ADAMTS13 activity (normal value > 50%); B2 = IgG and IgM antibodies to β2 glycoprotein I, aCL IgG and IgM antibodies to cardiolipin, LAC Lupus anti-coagulant antibodies, TnI Troponin I High Sensitivity, Prot Proteinuria (n.v. <0.15 g/L), C3c C3 complement protein (n.v. 90–180 mg/dL), C4 C4 complement protein (n.v. 8–32 mg/dL), CH50 50% Haemolytic Complement Activity (n.v. <70 Ueq/mL)